Skip to main content
. 2001 Sep;69(9):5456–5463. doi: 10.1128/IAI.69.9.5456-5463.2001

FIG. 4.

FIG. 4

Dose-dependent survival. CBA/N mice were immunized with the indicated amounts of pJB100 or 50 μg of pNGVL3 (control). Mice were challenged on day 35 with pneumococcal strain WU2. Data represent the results for four mice per group.